María José Larráyoz (María J Larráyoz, María José Larrayoz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Patients Undergoing

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Nature communications

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz, María-José Calasanz, José Luis Vizmanos
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia. Cancers 16 (8) (2024)
Ana Guijarro-Hernández, Cristina Hurtado, María José Larráyoz, María-José Calasanz, José Luis Vizmanos
CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia. Cancers 16 (8) (2024)
Edurne San José-Enériz, Naroa Gimenez-Camino, Obdulia Rabal, Leire Garate, Estibaliz Miranda, Nahia Gomez-Echarte, Fernando Garcίa, Stella Charalampopoulou, Elena Sáez, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Luis Vitores Valcárcel, Naroa Barrena, Diego Alignani, Luis Esteban Tamariz-Amador, Ana Pérez-Ruiz, Sebastian Hilscher, Mike Schutkowski, Ana Alfonso, Nicolás Martinez-Calle, María José Larráyoz, Juan José Lahuerta, María-José Calasanz, Javier Munoz, Marta Isasa, José Ignacio Martin-Subero, Antonio Pineda-Lucena, Julen Oyarzabal, Xabier Agirre, Felipe Prosper
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia. Nature communications 15 (1) (2024)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Claudia Sargas, Rosa María Ayala, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Esther Prados de la Torre, David Martínez-Cuadrón, Rebeca Rodríguez-Veiga, Blanca Boluda, Cristina Gil, Teresa Bernal Del Castillo, Juan Miguel Bergua, Lorenzo Algarra, María Del Mar Tormo Díaz, Pilar Martínez-Sánchez, Elena Soria, Josefina Serrano, Juan Manuel Alonso-Domínguez, Raimundo García-Boyero, María Luz Amigo, Pilar Herrera-Puente, María José Sayas, Esperanza Lavilla-Rubira, Joaquin Martinez Lopez, María-José Calasanz, Miriam Santero, José Antonio Pérez-Simón, María Teresa Gómez-Casares, Joaquín Sánchez-García, Eva Barragán, Pau Montesinos, null On Behalf Of Pethema Group
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 15 (2) (2023)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)
Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas, Alejandro Sanz, Lorenzo Algarra, Pilar Herrera-Puente, Raimundo García-Boyero, Manuel Barrios, David Martínez-Cuadrón, Rebeca Rodriguez-Veiga, Blanca Boluda, Cristina Gil, Josefina Serrano-López, Joaquin Martinez Lopez, María José Sayas-Lloris, María Teresa Olave, Rosalía Riaza-Grau, Teresa Bernal-Del Castillo, María José Larráyoz, Raquel Amigo, Antonio Jiménez-Velasco, Joaquín Sánchez, Rosa María Ayala, Carlos Blas López, Daniel Lainez-González, Juana Serrano-López, Miguel Angel Sanz, Juan Manuel Alonso-Domínguez, Pau Montesinos
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. Disease markers 2022 (2022)
Rosa Ayala, Gonzalo Carreño-Tarragona, Eva Barragán, Blanca Boluda, María José Larráyoz, María Carmen Chillón, Estrella Carrillo-Cruz, Cristina Bilbao-Sieyro, Joaquín Sánchez-García, Teresa Bernal, David Martínez-Cuadrón, Cristina Gil, Josefina Serrano, Carlos Rodriguez-Medina, Juan Bergua, José Antonio Pérez-Simón, María Calbacho, Juan Manuel Alonso-Domínguez, Jorge Labrador-Gomez, Mar Tormo, Maria Luz Amigo, Pilar Herrera-Puente, Inmaculada Rapado, Claudia Sargas, Iria Vazquez, María-José Calasanz, Teresa Gomez-Casares, Miriam Santero, Miguel Angel Sanz, Joaquin Martinez Lopez, Pau Montesinos
Impact of FLT3-ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study. Cancers 14 (23) (2022)